IDL Biotech meddelar att de har tecknat ett avtal med Beckman Coulter om licensiering av IDL Biotechs samtliga tumörmarkörer på den manuella plattformen radioimmunoassay (IRMA). Licensavtalet ger Beckman Coulter globala försäljningsrättigheter och möjliggör för IDL att erhålla royalties. Avtalet har formellt undertecknats av Immunotech, ett dotterbolag till Beckman Coulter.
Läs pressmeddelandet här.
AroCell participated at Redeye's Technology & Life Science day on December 3rd. CEO Anders Hultman presented the latest developments and future prospects of the company. The presentation is now available for listening below. AroCell: CEO Anders Hultman presenterar...
Arocell recently participated as an exhibitor at the Medica trade fair, joining 5,800 other exhibitors from 72 countries. Medica showcases modern healthcare solutions for both outpatients and inpatients, making it a pivotal event in the medical industry. We engaged in...
A delegation from Airlangga University and Dr. Soetomo General Hospital visited the AroCell/IDL Biotech office in Stockholm on Tuesday, 18th of June. The Indonesian Embassy in Sweden facilitated the meeting. Airlangga University, one of the oldest medical schools in...
